Bright Minds Biosciences Inc (DRUG) is trading up at $52.69 (+4.46%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
| FY2020Sep 2020 | FY2021Sep 2021 | FY2022Sep 2022 | FY2023Sep 2023 | FY2024Sep 2024 | |
|---|---|---|---|---|---|
| Income statement | |||||
| Net income | −CA$480.4K | −CA$8.65M | −CA$15.0M | −CA$7.37M | −CA$2.80M |
| EPS (diluted) | −CA$0.65 | −CA$4.82 | −CA$6.06 | −CA$1.98 | −CA$0.65 |
| Balance sheet | |||||
| Cash and equivalents | CA$799.9K | CA$19.8M | CA$11.6M | CA$6.75M | CA$5.72M |
| Total assets | CA$880.2K | CA$20.0M | CA$12.1M | CA$6.88M | CA$6.10M |
| Total liabilities | CA$150.9K | CA$638.6K | CA$1.54M | CA$280.9K | CA$568.3K |
| Shareholders' equity | CA$729.3K | CA$19.4M | CA$10.5M | CA$6.60M | CA$5.54M |
| Cash flow | |||||
| Operating cash flow | −CA$288.4K | −CA$7.32M | −CA$13.6M | −CA$7.02M | −CA$1.85M |
From Bright Minds Biosciences Inc's 20-F filings with the SEC; its fiscal year ends in September. Each period shows the latest figure the company has reported for it, including restatements. Amounts are in Canadian Dollar (CAD), as reported, not converted to dollars. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →